/

Sonoma Biotherapeutics

Developing targeted regulatory T cell therapies for autoimmune diseases.

BiotechnologyPharmaceuticals sonomabio.com ↗

Company facts

Founded: 2019
Employees: 150
Headquarters: United States
Type: Private
Funding: Series B · $265M · 2021